Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Vitamin D and calcium were the predominant treatments, while antiresorptive, anabolic, and dual effect agents were underused.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were classified as “Never users” if untreated throughout the study period or “Ever users” if treated at least once.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Underuse of osteoporosis treatments before and after hip fracture: longitudinal findings from the Gruppo Italiano di Ortogeriatria (GIOG 2.0) study
Study design awaiting verification · Frontiers in Aging · 2026
Original publication title
Underuse of osteoporosis treatments before and after hip fracture: longitudinal findings from the Gruppo Italiano di Ortogeriatria (GIOG 2.0) study
Copyright © 2026 Ferrara, Guo, Cucini, Ornago, Tassistro, Pinardi, Finazzi, Mazzola, Okoye, Valsecchi, Mussi, Sergi, Ungar, Antonelli Incalzi, Volpato and Bellelli.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Osteoporosis is a major cause of fragility fractures, with hip fracture (HF) representing the most severe complication in older adults. However, national data on osteoporosis treatment use before and after hip fracture in Italy are limited.
Source: BackgroundAbstract: What methods does the paper describe?
This multicenter prospective study included individuals aged ≥65 years admitted for HF between July 2019 and June 2024 at 12 orthogeriatric centers. Osteoporosis treatments (vitamin D, calcium, antiresorptive, anabolic, dual effect agents) were recorded at admission, discharge, and 120: and 365-day follow-ups. Patients were classified as “Never users” if untreated throughout the study period or “Ever users” if treated at least once. Multivariate logistic regression identified factors independently associated with lack of treatment.
Source: MethodsAbstract: Results
Among 1,012 patients (median age 83 years; 77.2% female), 85.6% were untreated at admission; this proportion dropped to 34.4% at discharge but rose again to 50% at 1 year. Vitamin D and calcium were the predominant treatments, while antiresorptive, anabolic, and dual effect agents were underused. Overall, 22% of patients were classified as “Never users”. They were generally older, more often male, and had higher comorbidity, dementia, frailty, and mobility limitations. Only male sex was independently associated with lack of treatment (Odds Ratio 2.37, 95% Confidence Intervals 1.59 to 3.55).
Source: ResultsAbstract: Conclusion
Despite clinical guideline recommendations, osteoporosis treatment remains suboptimal among older HF patients in Italy, especially in male patients. Findings support the need for national programs and multidisciplinary strategies to reduce the treatment gap and improve long-term management.
Source: ConclusionAuthors’ abstract
Background
Osteoporosis is a major cause of fragility fractures, with hip fracture (HF) representing the most severe complication in older adults. However, national data on osteoporosis treatment use before and after hip fracture in Italy are limited.
Methods
This multicenter prospective study included individuals aged ≥65 years admitted for HF between July 2019 and June 2024 at 12 orthogeriatric centers. Osteoporosis treatments (vitamin D, calcium, antiresorptive, anabolic, dual effect agents) were recorded at admission, discharge, and 120: and 365-day follow-ups. Patients were classified as “Never users” if untreated throughout the study period or “Ever users” if treated at least once. Multivariate logistic regression identified factors independently associated with lack of treatment.
Results
Among 1,012 patients (median age 83 years; 77.2% female), 85.6% were untreated at admission; this proportion dropped to 34.4% at discharge but rose again to 50% at 1 year. Vitamin D and calcium were the predominant treatments, while antiresorptive, anabolic, and dual effect agents were underused. Overall, 22% of patients were classified as “Never users”. They were generally older, more often male, and had higher comorbidity, dementia, frailty, and mobility limitations. Only male sex was independently associated with lack of treatment (Odds Ratio 2.37, 95% Confidence Intervals 1.59 to 3.55).
Conclusion
Despite clinical guideline recommendations, osteoporosis treatment remains suboptimal among older HF patients in Italy, especially in male patients. Findings support the need for national programs and multidisciplinary strategies to reduce the treatment gap and improve long-term management.
Publication and source details
Original title: Underuse of osteoporosis treatments before and after hip fracture: longitudinal findings from the Gruppo Italiano di Ortogeriatria (GIOG 2.0) study
Maria Cristina Ferrara; Wenxiang Guo; Eleonora Cucini; Alice Margherita Ornago; Elena Tassistro; Elena Pinardi; Alberto Finazzi; Paolo Mazzola; Chukwuma Okoye; Maria Grazia Valsecchi; Chiara Mussi; Giuseppe Sergi; Andrea Ungar; Raffaele Antonelli Incalzi; Stefano Volpato; Giuseppe Bellelli
Frontiers in Aging · 2026
* Correspondence: Wenxiang Guo, w.guo@campus.unimib.itThese authors have contributed equally to this work and share first authorship
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:24:50.200701+00:00
DOI: 10.3389/fragi.2026.1837212 · PMC13260223